Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity - PubMed (original) (raw)

Review

Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity

Fan-Cheng Meng et al. Chin Med. 2018.

Abstract

Background: Coptidis rhizoma (CR) is the dried rhizome of Coptis chinensis Franch., C. deltoidea C. Y. Cheng et Hsiao or C. teeta Wall. (Ranunculaceae) and is commonly used in Traditional Chinese Medicine for the treatment of various diseases including bacillary dysentery, typhoid, tuberculosis, epidemic cerebrospinal meningitis, empyrosis, pertussis, and other illnesses.

Methods: A literature survey was conducted via SciFinder, ScieneDirect, PubMed, Springer, and Wiley databases. A total of 139 selected references were classified on the basis of their research scopes, including chemical investigation, quality evaluation and pharmacological studies.

Results: Many types of secondary metabolites including alkaloids, lignans, phenylpropanoids, flavonoids, phenolic compounds, saccharides, and steroids have been isolated from CR. Among them, protoberberine-type alkaloids, such as berberine, palmatine, coptisine, epiberberine, jatrorrhizine, columamine, are the main components of CR. Quantitative determination of these alkaloids is a very important aspect in the quality evaluation of CR. In recent years, with the advances in isolation and detection technologies, many new instruments and methods have been developed for the quantitative and qualitative analysis of the main alkaloids from CR. The quality control of CR has provided safety for pharmacological applications. These quality evaluation methods are also frequently employed to screen the active components from CR. Various investigations have shown that CR and its main alkaloids exhibited many powerful pharmacological effects including anti-inflammatory, anti-cancer, anti-diabetic, neuroprotective, cardioprotective, hypoglycemic, anti-Alzheimer and hepatoprotective activities.

Conclusion: This review summarizes the recent phytochemical investigations, quality evaluation methods, the biological studies focusing on CR as well as its main alkaloids.

Keywords: Coptidis rhizoma; Coptis genus; Pharmacological effects; Phytochemistry; Quality evaluation.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Structures of alkaloids isolated from Coptis genus

Fig. 2

Fig. 2

Structures of lignans isolated from Coptis genus

Fig. 3

Fig. 3

Structures of phenylpropanoids isolated from Coptis genus

Fig. 4

Fig. 4

Structures of flavonoids isolated from Coptis genus

Fig. 5

Fig. 5

Structures of other compounds isolated from Coptis genus

Similar articles

Cited by

References

    1. Ren L, Xue X, Liang X. Characterization of protoberberine alkaloids in Coptidis rhizoma (Huanglian) by HPLC with ESI–MS/MS. J Sep Sci. 2013;36:1389–1396. doi: 10.1002/jssc.201201002. - DOI - PubMed
    1. Qian XC, Zhang L, Tao Y, Huang P, Li JS, Chai C, Li W, Di LQ, Cai BC. Simultaneous determination of ten alkaloids of crude and wine-processed rhizoma Coptidis aqueous extracts in rat plasma by UHPLC–ESI–MS/MS and its application to a comparative pharmacokinetic study. J. Pharm Biomed. 2015;105:64–73. doi: 10.1016/j.jpba.2014.11.049. - DOI - PubMed
    1. Fan G, Zhang MY, Zhou XD, Lai XR, Yue QH, Tang C, Luo WZ, Zhang Y. Quality evaluation and species differentiation of rhizoma Coptidis by using proton nuclear magnetic resonance spectroscopy. Anal Chim Acta. 2012;747:76–83. doi: 10.1016/j.aca.2012.08.038. - DOI - PubMed
    1. Chen X, Wang J, Hu S, Bai X. Hollow-fiber double-solvent synergistic microextraction with high-performance liquid chromatography for the determination of antitumor alkaloids in Coptis chinensis. J Sep Sci. 2016;39:827–834. doi: 10.1002/jssc.201501160. - DOI - PubMed
    1. Liu X, Hu S, Chen X, Bai X. Hollow fiber cell fishing with high-performance liquid chromatography for rapid screening and analysis of an antitumor-active protoberberine alkaloid group from Coptis chinensis. J Pharm Biomed. 2014;98:463–475. doi: 10.1016/j.jpba.2014.06.030. - DOI - PubMed

Publication types

LinkOut - more resources